Synthesis of naphthalimide derivatives bearing benzothiazole and thiazole moieties: In vitro anticancer and in silico ADMET study
作者:Pramod D. JawalePatil、Keerti Bhamidipati、Manoj G. Damale、Jaiprakash N. Sangshetti、Nagaprasad Puvvada、Rajesh S. Bhosale、Rajita D. Ingle、Rajendra P. Pawar、Sidhanath V. Bhosale、Sheshanath V. Bhosale
DOI:10.1016/j.molstruc.2022.133173
日期:2022.9
we report the synthesis and characterization of 1–16 new naphthalimide derivatives. These compounds 1–16 were tested for their anticancer activity against cancerous cells B16F10, MCF7, PANC1, and CHO cell lines. Among these substances, the derivatives 2 and 6 showed moderate cytotoxicity against B16F10 cell lines in vitro. Whereas, compound 14 exhibited excellent cytotoxic activity against B16F10
在此,我们报告了1-16种新型萘酰亚胺衍生物的合成和表征。测试了这些化合物1-16对癌细胞 B16F10、MCF7、PANC1 和 CHO 细胞系的抗癌活性。在这些物质中,衍生物2和6在体外对B16F10细胞系表现出中等的细胞毒性。而化合物14对 B16F10、MCF7 和 PANC1 细胞表现出优异的细胞毒活性。分子对接研究还表明,化合物2、6和14是有效的候选化合物,可用于药物发现过程中的先导。化合物的药代动力学和毒性特征通过对吸收、分布、代谢、消除和毒性 (ADMET) 参数的预测来访问1-16 。体外细胞系和分子对接研究结果表明,化合物2、6和14是进一步结构操作和评估新一代更有效的细胞毒剂的良好候选者。